Modern radiation therapy planning and image-guided radiotherapy using the example of prostate cancer

被引:0
作者
Koerber, Stefan A. [1 ,2 ,3 ]
Beuthien-Baumann, Bettina [4 ]
机构
[1] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[2] Natl Ctr Tumorerkrankungen NCT, Heidelberg, Germany
[3] Heidelberg Inst Radiat Oncol HIRO, Heidelberg, Germany
[4] Deutsch Krebsforschungszentrum DKFZ, Abt Radiol, Heidelberg, Germany
来源
RADIOLOGE | 2021年 / 61卷 / 01期
关键词
Prostate cancer; Multiparametric magnetic resonance imaging; Prostate-specific membrane antigen; Radiotherapy; MR-linac; BEAM COMPUTED-TOMOGRAPHY; TOXICITY; BOOST; CT;
D O I
10.1007/s00117-020-00763-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Clinical/methodical issue Optimizing radiotherapy demands precise delineation of the target structure, not only before but also during the course of radiotherapy. Standard radiological methods For many years, planning of external radiation treatment planning has been based on computer tomography data. Methodological innovations With the advent of image-guided radiotherapy (IGRT), magnetic resonance imaging (MRI) and functional hybrid imaging are increasingly being integrated into radiation treatment planning. The development of the MR-linac can be seen as an innovation. Performance The integration of MRI and hybrid imaging (positron emission tomography [PET]/CT, PET/MRI) in the treatment planning process enables more precise treatment planning due to the better morphological and functional information. The integration of MRI data on the MR-linac in daily position control enables adaptation of the irradiation plan to the current conditions. Achievements Technical innovation such as the MR-linac as well as increasing use of hybrid imaging contribute to the objective of further individualization within (radio)oncology. Practical recommendations Using the example of prostate cancer, the application of prostate-specific membrane antigen (PSMA) ligands and hybrid imaging offers great potential for individualized strategic treatment decisions. The MR-linac appears to be particularly suitable for radiation therapy of prostate cancer. Special attention must be paid to the technical aspects of positioning and data acquisition for the purpose of radiation treatment planning.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 38 条
[1]   Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality -of -Life Comparison of Two Prospective Trials [J].
Alayed, Yasir ;
Davidson, Melanie ;
Liu, Stanley ;
Chu, William ;
Tseng, Eric ;
Cheung, Patrick ;
Vesprini, Danny ;
Cheung, Hans ;
Morton, Gerard ;
Musunuru, H. B. ;
Ravi, Anath ;
Korol, Renee ;
Deabreu, Andrea ;
Ho, Ling ;
Commisso, Kristina ;
Bhounr, Zeeba ;
D'Alimonte, Laura ;
Mittmann, Nicole ;
Dragomir, Alice ;
Zhang, Liang ;
Loblaw, Andrew .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (01) :136-142
[2]  
Allison Ron R, 2006, Future Oncol, V2, P477, DOI 10.2217/14796694.2.4.477
[3]   1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment [J].
Alongi, Filippo ;
Rigo, Michele ;
Figlia, Vanessa ;
Cuccia, Francesco ;
Giaj-Levra, Niccolo ;
Nicosia, Luca ;
Ricchetti, Francesco ;
Sicignano, Gianluisa ;
De Simone, Antonio ;
Naccarato, Stefania ;
Ruggieri, Ruggero ;
Mazzola, Rosario .
RADIATION ONCOLOGY, 2020, 15 (01)
[4]   IMAGE-GUIDED RADIOTHERAPY (IGRT) FOR PROSTATE CANCER COMPARING kV IMAGING OF FIDUCIAL MARKERS WITH CONE BEAM COMPUTED TOMOGRAPHY (CBCT) [J].
Barney, Brandon M. ;
Lee, R. Jeffrey ;
Handrahan, Diana ;
Welsh, Keith T. ;
Cook, J. Taylor ;
Sause, William T. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01) :301-305
[5]   Accuracy of ultrasound-based (BAT) prostate-repositioning:: A three-dimensional on-line fiducial-based assessment with cone-beam computed tomography [J].
Boda-Heggemann, Judit ;
Koehler, Frederick Marc ;
Koepper, Beate ;
Wolff, Dirk ;
Wertz, Hansjoerg ;
Mai, Sabine ;
Hesser, Jorgen ;
Lohr, Frank ;
Wenz, Frederik .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1247-1255
[6]  
Bostel T, 2018, STRAHLENTHER ONKOL, V194, P425, DOI 10.1007/s00066-017-1258-y
[7]   A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results [J].
Bruynzeel, Anna M. E. ;
Tetar, Shyama U. ;
Oei, Swie S. ;
Senan, Suresh ;
Haasbeek, Cornelis J. A. ;
Spoelstra, Femke O. B. ;
Piet, Anna H. M. ;
Meijnen, Philip ;
van der Jagt, Marjolein A. B. Bakker ;
Fraikin, Tamara ;
Slotman, Berend J. ;
van Moorselaar, Reindert J. A. ;
Lagerwaard, Frank J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (05) :1086-1094
[8]   Analysis of interfraction prostate motion using megavoltage cone beam computed tomography [J].
Bylund, Kevin C. ;
Bayouth, John E. ;
Smith, Mark C. ;
Hass, A. Curtis ;
Bhatia, Sudershan K. ;
Buatti, John M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03) :949-956
[9]   DOES IMAGE-GUIDED RADIOTHERAPY IMPROVE TOXICITY PROFILE IN WHOLE PELVIC-TREATED HIGH-RISK PROSTATE CANCER? COMPARISON BETWEEN IG-IMRT AND IMRT [J].
Chung, Hans T. ;
Xia, Ping ;
Chan, Linda W. ;
Park-Somers, Eileen ;
Roach, Mack, III .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01) :53-60
[10]   Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer [J].
Draulans, Cedric ;
van der Heide, Uulke A. ;
Haustermans, Karin ;
Pos, Floris J. ;
van Zyp, Jochem van der Voort ;
De Boer, Hans ;
Groen, Veerle H. ;
Monninkhof, Evelyn M. ;
Smeenk, Robert J. ;
Kunze-Busch, Martina ;
De Roover, Robin ;
Depuydt, Tom ;
Isebaert, Sofie ;
Kerkmeijer, Linda G. W. .
RADIOTHERAPY AND ONCOLOGY, 2020, 147 :92-98